Bill > S1607

This bill establishes dedicated Inspector General (IG) positions for three major federal health agencies: the National Institutes of Health (NIH), the Centers for Disease Control and Prevention (CDC), and the Food and Drug Administration (FDA). Specifically, the bill amends existing law to include these agencies in the definitions of organizations required to have an Inspector General, and mandates that the President appoint individual IGs to these positions within one year of the bill's enactment. An Inspector General is a government official responsible for conducting independent oversight, investigating potential misconduct, and promoting efficiency and accountability within their respective organization. The bill ensures that these new IG positions will be funded through existing appropriations from the Department of Health and Human Services' Office of the Inspector General, meaning no additional funding will be required. By creating these dedicated oversight roles, the bill aims to enhance transparency, integrity, and performance in these critical public health agencies, which play key roles in medical research, disease prevention, and regulation of medical products and food safety.

Health and Social Services

https://www.congress.gov/bill/119th-congress/senate-bill/1607/all-info